ایپسن

Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales.

Key facts

Company.name: Ipsen
Company.logo: Logo_Ipsen.jpg
Company.location: Balard, Paris 15, France
Company.industry: Pharmaceutical
Company.key_people: Marc de Garidel (Non-executive Chairman) David Loew (Chief Executive Officer)
Company.products: List of medicines
Company.revenue: (2024)
Company.operating_income: (2024)
Company.net_income: (2024)
Company.num_employees: 5,300
Company.homepage: www.ipsen.com
Company.foundation: 1929
Company.founder: Henri Beaufour
Company.type: Public
Company.traded_as: CAC Mid 60 Component

via Wikipedia infobox

Company

Jurisdiction: FR
Headquarters: PARIS, FR

via GLEIF

Research organization · ROR

Type: Company, Funder
Founded: 1929
Location: Paris, France
Status: Active

Website →Wikipedia →ROR →

GRID grid.476474.2 · ISNI 0000 0001 1957 4504

Wikidata facts

Instance of: organization
Official name: IPSEN
Country: France
Industry: pharmaceutical industry
Employees: 5300
Revenue: 3400000000
Stock exchange: Euronext
Official website: www.ipsen.com

Show 4 more facts

inception: 1929-01-01
social media followers: 4864
net profit: 347000000
number of viewers/listeners: 667676

Sources (10)

via Wikidata · CC0

Available in 14 languages

via Wikidata sitelinks · CC0